SMP30 alleviates cerebral ischemia/reperfusion-induced neuronal injury by inhibiting HDAC4/PSD-95 to preserve mitochondrial function
Journal of Neuropathology & Experimental Neurology · 2025
DOI: 10.1093/jnen/nlae095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2025. Verfasst von Rundong Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China. Hauptthemen laut MEDLINE: Disks Large Homolog 4 Protein, Reperfusion Injury, Mitochondria, Histone Deacetylases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Ischemic stroke is a major cause of global death and permanent disability. Major consequences of ischemic stroke include neuronal mitochondrial dysfunction. We investigated the effects of senescence marker protein 30 (SMP30) on mitochondria-mediated apoptosis and histone deacetylase 4 (HDAC4)/postsynaptic density-95 (PSD-95) signaling in stroke models in vivo and in vitro. Rats with middle cerebral artery occlusion/reperfusion (MCAO/R) were used to simulate cerebral ischemia/reperfusion (I/R) injury. SMP30 was downregulated in the brain tissues of rats after I/R induction. SMP30 overexpression decreased MCAO/R-induced infarct volumes and improved neurologic function and histopathological changes. Increasing SMP30 expression suppressed neuronal apoptosis and reduced mitochondrial dysfunction. SMP30 overexpression in SH-SY5Y and PC12 cells treated with oxygen-glucose deprivation/reoxygenation (OGD/R) decreased HDAC4 and PSD-95 expression; PSD-95 could bind to HDAC4. Furthermore, HDAC4 upregulation abolished the effects of SMP30 overexpression on OGD/R-induced apoptosis and mitochondrial dysfunction in SH-SY5Y cells. Together, these findings indicate that SMP30 alleviates cerebral I/R-induced neuronal injury by inhibiting HDAC4/PSD-95 to preserve mitochondrial function. These interactions might provide new treatment methods for patients with ischemic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
- Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
- Gerontology, Changhai Hospital, Naval Medical University, Shanghai, China.
- Department of Neurosurgery, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Zitieren
APA
Chen, R., Qian, L., Zhang, Q., Qin, J., Chen, X., & Xu, X. (2025). SMP30 alleviates cerebral ischemia/reperfusion-induced neuronal injury by inhibiting HDAC4/PSD-95 to preserve mitochondrial function. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlae095
Vancouver
Chen R, Qian L, Zhang Q, Qin J, Chen X, Xu X. SMP30 alleviates cerebral ischemia/reperfusion-induced neuronal injury by inhibiting HDAC4/PSD-95 to preserve mitochondrial function. Journal of Neuropathology & Experimental Neurology. 2025. doi:10.1093/jnen/nlae095
BibTeX
@article{Chen2025,
author = {Chen, Rundong and Qian, Lei and Zhang, Qian and Qin, Jiajun and Chen, Xianzhen and Xu, Xiaolong},
title = {SMP30 alleviates cerebral ischemia/reperfusion-induced neuronal injury by inhibiting HDAC4/PSD-95 to preserve mitochondrial function},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2025},
doi = {10.1093/jnen/nlae095}
}
EUVIMED